Pages

Tuesday, March 28, 2017

FDA approves 1st drug for moderate & severe eczema cases

... list price of $37,000 per year, according to Paris, France-based Sanofi SA and Regeneron Pharmaceuticals of Tarrytown, New York, which developed the drug. Eczema treatments have generally been limited to topical medications, steroid creams, ...
http://ift.tt/2nrj1wH

No comments:

Post a Comment